Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 3 Interventional

Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes

ClinicalTrials.gov ID: NCT07284901

Public ClinicalTrials.gov record NCT07284901. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 19, 2026, 11:22 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of KAI-9531 Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The primary objective of this study is to demonstrate that ribupatide (KAI-9531) subcutaneous (SC) injection once weekly is superior to placebo on: * Percent change in body weight * Change in hemoglobin A1c (HbA1c)

Study identification

NCT ID
NCT07284901
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Kailera
Industry
Enrollment
1,270 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 12, 2026 (Actual)
Primary completion
Mar 27, 2028 (Estimated)
Completion
Apr 24, 2028 (Estimated)
Last update posted
Oct 6, 2026

2026 – 2028

United States locations

U.S. sites
62
U.S. states
27
U.S. cities
60
Facility City State ZIP Site status
Kailera Clinical Site Cullman Alabama 35055 —
Kailera Clinical Site Phoenix Arizona 85012 —
Kailera Clinical Site Sun City Arizona 85351 —
Kailera Clinical Site Little Rock Arkansas 72205 —
Kailera Clinical Site Escondido California 92025 —
Kailera Clinical Site La Mesa California 91942 —
Kailera Clinical Site Montclair California 91763 —
Kailera Clinical Site Northridge California 91325 —
Kailera Clinical Site Oceanside California 92058 —
Kailera Clinical Site Toluca Lake California 91602 —
Kailera Clinical Site Stamford Connecticut 06905 —
Kailera Clinical Site Bradenton Florida 34209 —
Kailera Clinical Site Hollywood Florida 33024 —
Kailera Clinical Site Jupiter Florida 33458 —
Kailera Clinical Site Miami Florida 33135 —
Kailera Clinical Site Miami Lakes Florida 33016 —
Kailera Clinical Site Orange City Florida 32763 —
Kailera Clinical Site Orlando Florida 32801 —
Kailera Clinical Site Orlando Florida 32803 —
Kailera Clinical Site The Villages Florida 32162 —
Kailera Clinical Site Decatur Georgia 30030 —
Kailera Clinical Site Lilburn Georgia 30047 —
Kailera Clinical Site Marietta Georgia 30060 —
Kailera Clinical Site Riverdale Georgia 30274 —
Kailera Clinical Site Skokie Illinois 60077 —
Kailera Clinical Site Springfield Illinois 62702 —
Kailera Clinical Site Newton Kansas 67114 —
Kailera Clinical Site Shreveport Louisiana 71105 —
Kailera Clinical Site Annapolis Maryland 21401 —
Kailera Clinical Site Columbia Maryland 21045 —
Kailera Clinical Site Boston Massachusetts 02115 —
Kailera Clinical Site Farmington Hills Michigan 48334 —
Kailera Clinical Site Missoula Montana 59804 —
Kailera Clinical Site Lincoln Nebraska 68516 —
Kailera Clinical Site Las Vegas Nevada 89148 —
Kailera Clinical Site Albany New York 12203 —
Kailera Clinical Site Laurelton New York 11413 —
Kailera Clinical Site New York New York 10016 —
Kailera Clinical Site Greensboro North Carolina 27405 —
Kailera Clinical Site Monroe North Carolina 28112 —
Kailera Clinical Site #1 Morehead City North Carolina 28557 —
Kailera Clinical Site #2 Morehead City North Carolina 28557 —
Kailera Clinical Site Morrisville North Carolina 27560 —
Kailera Clinical Site Cleveland Ohio 44122 —
Kailera Clinical Site Chickasha Oklahoma 73018 —
Kailera Clinical Site East Greenwich Rhode Island 02818 —
Kailera Clinical Site Spartanburg South Carolina 29303 —
Kailera Clinical Site Chattanooga Tennessee 37405 —
Kailera Clinical Site Memphis Tennessee 38119 —
Kailera Clinical Site Amarillo Texas 79124 —
Kailera Clinical Site Brownsville Texas 78526 —
Kailera Clinical Site DeSoto Texas 75115 —
Kailera Clinical Site El Paso Texas 79902 —
Kailera Clinical Site Farmers Branch Texas 75234 —
Kailera Clinical Site Kingwood Texas 77345 —
Kailera Clinical Site Plano Texas 75093 —
Kailera Clinical Site Tomball Texas 77375 —
Kailera Clinical Site Pleasant View Utah 84404 —
Kailera Clinical Site Salt Lake City Utah 84117 —
Kailera Clinical Site Manassas Virginia 20110 —
Kailera Clinical Site Richmond Virginia 23236 —
Kailera Clinical Site Seattle Washington 98104 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 111 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07284901, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 6, 2026 · Synced Oct 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT07284901 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →